Jehn, L.B.; Costabel, U.; Boerner, E.; Wälscher, J.; Theegarten, D.; Taube, C.; Bonella, F.
Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease. J. Clin. Med. 2023, 12, 1173.
https://doi.org/10.3390/jcm12031173
AMA Style
Jehn LB, Costabel U, Boerner E, Wälscher J, Theegarten D, Taube C, Bonella F.
Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease. Journal of Clinical Medicine. 2023; 12(3):1173.
https://doi.org/10.3390/jcm12031173
Chicago/Turabian Style
Jehn, Lutz B., Ulrich Costabel, Eda Boerner, Julia Wälscher, Dirk Theegarten, Christian Taube, and Francesco Bonella.
2023. "Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease" Journal of Clinical Medicine 12, no. 3: 1173.
https://doi.org/10.3390/jcm12031173
APA Style
Jehn, L. B., Costabel, U., Boerner, E., Wälscher, J., Theegarten, D., Taube, C., & Bonella, F.
(2023). Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease. Journal of Clinical Medicine, 12(3), 1173.
https://doi.org/10.3390/jcm12031173